Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic
Elizabeth Price, Elizabeth MacPhie, Lesley Kay, Peter Lanyon, Bridget Griffiths, Christopher Holroyd, Abhishek Abhishek, Taryn Youngstein, Kathryn Bailey, Jacqui Clinch, Muddassir Shaikh and Ali Rivett
DOI: https://doi.org/10.7861/clinmed.2020-0149
Clin Med May 2020 Elizabeth Price
AGreat Western Hospital, Swindon, UK and president, British Society for Rheumatology, London, UK
Roles: consultant rheumatologist
Elizabeth MacPhie
BLancashire and South Cumbria NHS Foundation Trust, Preston, UK and chair of the Clinical Affairs Committee, British Society for Rheumatology, London, UK
Roles: consultant rheumatologist
Lesley Kay
CThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK and joint national clinical lead for rheumatology, NHS England and Improvement, London, UK
Roles: consultant rheumatologist
Peter Lanyon
DNottingham University Hospitals NHS Trust, Nottingham, UK and national clinical co-lead for rheumatology, NHS Improvement, London, UK
Roles: consultant rheumatologist
Bridget Griffiths
ENewcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK and chair of the Specialised Rheumatology Clinical Reference Group, NHS England, London, UK
Roles: consultant rheumatologist
Christopher Holroyd
FUniversity Hospital Southampton, Southampton, UK
Roles: consultant rheumatologist
Abhishek Abhishek
GThe University of Nottingham, Nottingham, UK and Nottingham Biomedical Research Centre, Nottingham, UK
Roles: clinical associate professor of rheumatology
Taryn Youngstein
HHammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK
Roles: consultant rheumatologist
Kathryn Bailey
IOxford University Hospitals NHS Foundation Trust, Oxford, UK
Roles: consultant paediatric rheumatologist
Jacqui Clinch
JBristol Royal Hospital for Children, Bristol, UK and medical lead, Bath Centre for Pain Services, Bath, UK
Roles: consultant paediatric rheumatologist
Muddassir Shaikh
KJames Cook University Hospital, Middlesbrough, UK
Roles: consultant rheumatologist
Ali Rivett
LBritish Society for Rheumatology, London, UK
Roles: chief executive officer
Article Tools
Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic
Elizabeth Price, Elizabeth MacPhie, Lesley Kay, Peter Lanyon, Bridget Griffiths, Christopher Holroyd, Abhishek Abhishek, Taryn Youngstein, Kathryn Bailey, Jacqui Clinch, Muddassir Shaikh, Ali Rivett
Clinical Medicine May 2020, 20 (3) 256-261; DOI: 10.7861/clinmed.2020-0149
Citation Manager Formats
Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic
Elizabeth Price, Elizabeth MacPhie, Lesley Kay, Peter Lanyon, Bridget Griffiths, Christopher Holroyd, Abhishek Abhishek, Taryn Youngstein, Kathryn Bailey, Jacqui Clinch, Muddassir Shaikh, Ali Rivett
Clinical Medicine May 2020, 20 (3) 256-261; DOI: 10.7861/clinmed.2020-0149
Jump to section
- Article
- ABSTRACT
- Introduction
- Process
- COVID-19 and immunosuppressive drugs
- Corticosteroids
- Cyclophosphamide
- Biologic agents
- Small molecule JAK inhibitors
- Conventional disease modifying anti-rheumatic drugs (DMARDS) and infection risk
- Combination therapy
- Comorbidities and disease activity
- Reaching a consensus
- Identifying patients
- Conclusion
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.